Showing results (2221-2230 of 4,401) with videos related to

Sort By:
Pageof 441
ACS Medicinal Chemistry Letters|October 24, 2017
Discovery of VU6005649, a CNS Penetrant mGlu7/8 Receptor PAM Derived from a Series of Pyrazolo[1,5-a]pyrimidinesMasahito Abe, Mabel Seto, Rocco G Gogliotti, et al.
ACS Medicinal Chemistry Letters|July 21, 2022
Discovery and Characterization of a Novel Series of Chloropyrimidines as Covalent Inhibitors of the Kinase MSK1Adrian Hall, Jan Abendroth, Madison J Bolejack, et al.
ACS Medicinal Chemistry Letters|July 21, 2022
Combinatorial Optimization of Activity-Based Probes for Acyl Protein Thioesterases 1 and 2Roeland Vanhoutte, Steven H L Verhelst
ACS Medicinal Chemistry Letters|July 21, 2022
Design, Synthesis, and Biological Activity of l-1'-Homologated Adenosine DerivativesMai Nguyen, Seungchan An, Yen Nguyen, et al.
ACS Medicinal Chemistry Letters|July 21, 2022
Discovery of Tenapanor: A First-in-Class Minimally Systemic Inhibitor of Intestinal Na+/H+ Exchanger Isoform 3Jeffrey W Jacobs, Michael R Leadbetter, Noah Bell, et al.
ACS Medicinal Chemistry Letters|July 21, 2022
Novel Isoindolinone-Based Analogs of the Natural Cyclic Peptide Fenestin A: Synthesis and Antitumor ActivityHuanli Zhang, Jingwan Wu, Jingchun Wang, et al.
ACS Medicinal Chemistry Letters|July 21, 2022
Designing a Small Fluorescent Inhibitor to Investigate Soluble Epoxide Hydrolase Engagement in Living CellsSteffen Brunst, Julia Schönfeld, Peter Breunig, et al.
ACS Medicinal Chemistry Letters|September 19, 2019
One-step Heck Reaction Generates Nonimmunosuppressive FK506 Analogs for Pharmacological BMP ActivationYuefan Wang, Brandon J Peiffer, Qi Su, et al.
ACS Medicinal Chemistry Letters|September 19, 2019
Systematically Mitigating the p38α Activity of Triazole-based BET InhibitorsAngela S Carlson, Huarui Cui, Anand Divakaran, et al.
Pageof 441